AKT1 and Alzheimer disease: Increased Akt activation and mTOR phosphorylation have been reported in brains of AD patients, which is associated with a disrupted clearance of Aβ and tau, synaptic loss, and cognitive decline (Heras-Sandoval et al., 2014).